ilmscore | Prediction Details
"some of them might replace 70% of what they lose in rev limit some companies might at best replace 100% of what they lose in rev limit but it's somewhere between 50 to 100% of what you lose you will be able to replace but you will not probably offset more than what rev limit is giving to"
By Groww | April 24, 2025 | Pending
From video
Sensex, Nifty rally pauses; FMCG & realty stocks fall | Tariff-proofing your pharma portfolio 00:24:07 - 00:24:28
Interpreted Prediction
Pharma companies are predicted to be able to replace 50-100% of the revenue/profit lost from Revlimid generic expiry through new approvals, but not exceed Revlimid's current contribution.

Prediction Details

Topic
Pharma / Drug Exclusivity

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.